Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The Howie Code: what are the real costs?

C H Collins, J W Howie

    Journal of Clinical Pathology
    |January 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Implementing the Code of Practice for Infection Prevention in Clinical Laboratories incurred inflated costs. These expenses stemmed from unnecessary upgrades, building rectifications, poor lab design, and inefficient management practices.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Toward cell-free biofuel production: Stable immobilization of oligomeric enzymes.

    Biotechnology progress·2014
    Same author

    BROWN-SÉQUARD SYNDROME: A Case of Unusual Ætiology.

    Journal of neurology and psychiatry·2011
    Same author

    Observations on NUTRITION IN RELATION TO ANAEMIA.

    British medical journal·2010
    Same author

    Effect of shock-producing substances on experimental anthrax infection in mice.

    The Journal of pathology and bacteriology·2010
    Same author

    Speciation of aqueous chromium(VI) solutions with the aid of Q-mode factor analysis followed by oblique projection.

    Talanta·2008
    Same author

    Chromosomal instability at a mutational hotspot in polyoma middle T-antigen affects its ability to activate the ARF-p53 tumor suppressor pathway.

    Oncogene·2005
    Same journal

    Defining biochemical, pathological and molecular factors prognostic in terms of disease control and survival in high-grade extremity soft tissue sarcoma: a scoping review.

    Journal of clinical pathology·2026
    Same journal

    MILGDF: a multi-task, instance-level supervised model for oral squamous cell carcinoma integrating local-global attention and dynamic decision fusion.

    Journal of clinical pathology·2026
    Same journal

    Paediatric B-lymphoblastic leukaemia with low peripheral blasts: a potential diagnostic pitfall.

    Journal of clinical pathology·2026
    Same journal

    MRI-targeted versus systematic needle core biopsies in prostate cancer: a patient-based analysis of potential diagnostic and biologic underestimation.

    Journal of clinical pathology·2026
    Same journal

    Basal plasmacytosis and eosinophilia for distinguishing inflammatory bowel disease from gastrointestinal tuberculosis on mucosal biopsy.

    Journal of clinical pathology·2026
    Same journal

    Assay-dependent variability in free thyroxine (FT4): differential interference related to immunoassay design in a patient with subclinical hypothyroidism.

    Journal of clinical pathology·2026
    See all related articles

    Area of Science:

    • Healthcare Management
    • Laboratory Safety
    • Infection Control

    Background:

    • The Code of Practice for the Prevention of Infection in Clinical Laboratories aims to standardize safety protocols.
    • Accurate cost assessment is crucial for effective resource allocation in healthcare settings.

    Purpose of the Study:

    • To critically evaluate the actual costs associated with implementing the Code of Practice for Infection Prevention in Clinical Laboratories.
    • To identify factors contributing to inflated implementation costs.

    Main Methods:

    • Analysis of documented expenses related to Code of Practice implementation.
    • Review of laboratory infrastructure, management, and training records.
    • Comparison of actual expenditures against Code requirements.

    Related Experiment Videos

    Main Results:

    • Implementation costs were inflated due to factors beyond the Code's requirements.
    • Significant expenses included building alterations, rehabilitation of neglected facilities, and correction of poor laboratory design.
    • Suboptimal management, inadequate training, and excessive committee structures also contributed to inflated costs.

    Conclusions:

    • The financial burden of implementing infection prevention codes in clinical laboratories can be significantly higher than anticipated.
    • Addressing factors such as building compliance, design flaws, and operational inefficiencies is essential for cost-effective implementation.